Retrospective analysis of outcomes following prolapse surgery with and without the use of alloplastic material.
Recruiting
- Conditions
- N81Female genital prolapse
- Registration Number
- DRKS00031971
- Lead Sponsor
- niversitätsfrauenklinik Ulm
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Female
- Target Recruitment
- 782
Inclusion Criteria
Operative therapy (OPS code 5-704...)
vaginal prolapse surgeries without alloplastic material
vs
vaginal prolapse surgeries with alloplastic material
vs
laparoscopic/open sacrocolpopexy with alloplastic material
Exclusion Criteria
For patients who cannot be reached by phone and/or whose written consent form is not available, only the perioperative data from the electronic medical records will be collected retrospectively.
Study & Design
- Study Type
- observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Evaluation of treatment satisfaction, based on the Freiburg Patient Satisfaction Index, in the surgical therapy of genital prolapse depending on the surgical technique (alloplastic material versus autologous tissue).<br>Evaluation of the complication rate and type of complication in the surgical therapy of genital prolapse depending on the surgical technique (alloplastic material versus autologous tissue).
- Secondary Outcome Measures
Name Time Method The secondary study objective is to examine the relationship between patient-dependent co-factors and the rate and type of complications.
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie the success of prolapse surgeries using alloplastic mesh materials?
How does the use of alloplastic material in prolapse surgery compare to standard-of-care techniques in terms of long-term effectiveness and recurrence rates?
Are there specific biomarkers that can predict patient outcomes following prolapse surgery with or without alloplastic mesh?
What are the known adverse events associated with alloplastic mesh in pelvic organ prolapse repair and how are they managed?
What are the current trends in combination therapies or alternative materials for pelvic organ prolapse treatment compared to the approach in DRKS00031971?